• About us
    • About Lindahl
    • How we work
    • Said about Lindahl
    • Press
    • Find us
    • Privacy
  • Areas
    • Commercial dispute resolution
    • IT/Tech
    • Intellectual property
    • Life Sciences
    • M&A
    • All areas
  • Our people
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Helsingborg
    • Örebro
  • Latest news
    • Cases and transactions
    • News
    • Events
    • Knowledge
    • Portraits
  • Offices
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Örebro
    • Helsingborg

Lindahl assists when Senzime out-licenses a medical device for the European market

  • Home
  • Latest news
  • Cases and transactions
  • 2020
  • Lindahl assists when Senzime out-licenses a medical device for the European market

Lindahl acted as the legal advisor for Senzime AB (publ) when it out-licenses its medical device product OnZurf® Probe to the Italian medical device company MOSS S.pA and for the European market. The OnZurf® Probe is designed to enable continuous sampling from gastro-intestinal organs such as esophagus, stomach, and liver. By monitoring the organ surface, it is possible to detect elevations in lactate and other metabolic markers as early indicators of ischemia and post-operative complications.

As a result of the licensing agreement, Senzime will transfer the legal manufacturing rights and all related product liabilities related to the OnZurf Probe to MOSS, including any future development costs. Senzime will keep rights to commercialize OnZurf Probe on all markets outside of Europe.  

MOSS will pay Senzime a fixed license royalty per unit sold on the European market over a period of 10 years. The fixed royalty level corresponds to a double-digit percentage of OnZurf Probe’s estimated sales value. The forecasted royalty income to Senzime during the agreement period amounts to more than SEK 100 million and the first royalty payments are expected to occur in 2022. 

Lindahl’s team consisted of av Hugo Norlén, Erika Svensson och Amanda Sjöberg.

For further reading: https://www.senzime.com/cisionpost/?post=83EE4C850A41E505

 

Contact

  • Hugo Norlén

    Uppsala

    hugo.norlen@lindahl.se +46 702 718 189
  • Erika Svensson

    Uppsala

    erika.svensson@lindahl.se +46 704 215 839
Pages
  • Start
  • About us
  • Areas
  • Our people
  • Latest news
  • Privacy
Our offices
  • Stockholm reception.stockholm@lindahl.se +46 8 527 70 800
  • Göteborg reception.goteborg@lindahl.se +46 31 799 10 00
  • Malmö reception.malmo@lindahl.se +46 40 664 66 50
  • Uppsala reception.uppsala@lindahl.se +46 18 16 18 50
  • Örebro reception.orebro@lindahl.se +46 19 20 89 00
  • Helsingborg reception.helsingborg@lindahl.se +46 42 17 53 00
Social media
  • Connect with us on social networks: Instagram, Linkedin, Youtube, Facebook,

Disclaimer

The material and information on this site is intended for general informational purposes only and does not constitute legal advice on any specific matter. Please note that all images on Lindahl's website, www.lindahl.se, are subject to intellectual property protection and downloading, publication, copying and/or other use of the images requires the written consent of the rights holder. You'll find Advokatfirman Lindahl KB's general terms and conditions here.

Some cookies are essential, others help us improve your experience by providing insights into how the site is used. For more information, please visit our Cookie Policy.

Essential Cookies

These cookies are necessary for the functionality of the site and cannot be disabled.

Analytics Cookies>

We use Analytics cookies to collect information that gives us insight into how our website is being used. We anonymize IP addresses in Google Analytics. By clicking on Decline we won't save theese cookies.

Decline
We use cookies to get insights on how our site is used and give our visitors the best possible experience